Cleared Traditional

K111660 - XELIS CARDIAC

K111660 is an FDA 510(k) clearance for XELIS CARDIAC, manufactured by Infinitt Co., Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K111660 · Infinitt Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2011
Decision
91d
Days
Class 2
Risk

K111660 is an FDA 510(k) clearance for the XELIS CARDIAC. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Infinitt Co., Ltd. (Corinth, US). The FDA issued a Cleared decision on September 13, 2011 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Infinitt Co., Ltd. devices

FDA 510(k) Submission Details - K111660

510(k) Number K111660 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 2011
Decision Date September 13, 2011
Days to Decision 91 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 107d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1900
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K111660.
FEEL-DRCS
K110033 · Imfou Co., Ltd. · Sep 2011
ASTRA
K111694 · Candelis, Inc. · Sep 2011
MOLECULAR BREAST IMAGING SOFTWARE
K111731 · Gamma Medica-Ideas Incorporated · Sep 2011
RESOLUTIONMD MOBILE MODEL RMB-MOB-2X
K111346 · Calgary Scientific, Inc. · Sep 2011
XELIS FUSION
K111613 · Infinitt Co., Ltd. · Sep 2011
AIDA HD CONNECT WITH SMARTSCREEN / BLU-RAY DRIVE / SMARTSCREEN WITH BLU-RAY DRIVE
K103308 · KARL STORZ Endoscopy-America, Inc. · Aug 2011